Canopy Growth Corp (CGC)
3.91
+0.05
(+1.30%)
USD |
NASDAQ |
Nov 22, 16:00
3.91
0.00 (0.00%)
After-Hours: 20:00
Canopy Growth Revenue (Quarterly): 46.16M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 46.16M |
| June 30, 2024 | 48.38M |
| March 31, 2024 | 53.97M |
| December 31, 2023 | 57.67M |
| September 30, 2023 | 51.86M |
| June 30, 2023 | 56.69M |
| March 31, 2023 | 50.43M |
| December 31, 2022 | 62.47M |
| September 30, 2022 | 67.35M |
| June 30, 2022 | 82.89M |
| March 31, 2022 | 52.98M |
| December 31, 2021 | 111.84M |
| September 30, 2021 | 104.31M |
| June 30, 2021 | 110.91M |
| March 31, 2021 | 117.12M |
| December 31, 2020 | 117.04M |
| September 30, 2020 | 101.50M |
| June 30, 2020 | 79.65M |
| March 31, 2020 | 80.48M |
| December 31, 2019 | 93.75M |
| September 30, 2019 | 57.99M |
| June 30, 2019 | 67.61M |
| March 31, 2019 | 70.71M |
| December 31, 2018 | 62.80M |
| September 30, 2018 | 17.84M |
| Date | Value |
|---|---|
| June 30, 2018 | 20.08M |
| March 31, 2018 | 18.06M |
| December 31, 2017 | 17.06M |
| September 30, 2017 | 14.02M |
| June 30, 2017 | 11.80M |
| March 31, 2017 | 11.07M |
| December 31, 2016 | 7.307M |
| September 30, 2016 | 6.516M |
| June 30, 2016 | 5.420M |
| March 31, 2016 | 3.674M |
| December 31, 2015 | 2.606M |
| September 30, 2015 | 1.885M |
| June 30, 2015 | 1.391M |
| December 31, 2014 | 0.564M |
| September 30, 2014 | 0.2903M |
| June 30, 2014 | 0.173M |
| March 31, 2014 | |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.001M |
| July 31, 2013 | 0.001M |
| April 30, 2013 | 0.0009M |
| January 31, 2013 | 0.001M |
| October 31, 2012 | 0.0012M |
| July 31, 2012 | 0.0012M |
| April 30, 2012 | 0.0012M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
46.16M
Minimum
Sep 2024
117.12M
Maximum
Mar 2021
77.37M
Average
73.50M
Median
Revenue (Quarterly) Benchmarks
| Tilray Brands Inc | 200.04M |
| Aurinia Pharmaceuticals Inc | 67.77M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| Xenon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -94.01M |
| Total Expenses (Quarterly) | 61.68M |
| EPS Diluted (Quarterly) | -1.084 |
| Enterprise Value | 645.48M |
| Gross Profit Margin (Quarterly) | 34.67% |
| Profit Margin (Quarterly) | -203.7% |
| Earnings Yield | -120.3% |
| Normalized Earnings Yield | -68.65 |